Publicação
Unrecognized Fibrinogen A α-Chain Amyloidosis: Results From Targeted Genetic Testing
| dc.contributor.author | Tavares, Isabel | |
| dc.contributor.author | Oliveira, João Paulo | |
| dc.contributor.author | Pinho, Ana | |
| dc.contributor.author | Moreira, Luciana | |
| dc.contributor.author | Rocha, Liliana | |
| dc.contributor.author | Santos, Josefina | |
| dc.contributor.author | Pinheiro, Joaquim | |
| dc.contributor.author | Costa, Paulo Pinho | |
| dc.contributor.author | Lobato, Luísa | |
| dc.date.accessioned | 2018-03-23T11:20:19Z | |
| dc.date.available | 2018-03-23T11:20:19Z | |
| dc.date.issued | 2017-08 | |
| dc.description.abstract | Fibrinogen A α-chain (AFib) amyloidosis results from autosomal-dominant mutations in the gene encoding AFib (FGA). Patients with this disorder typically present with proteinuria. Isolated cases of AFib amyloidosis, carrying the FGA p.Glu545Val variant, were identified in the district of Braga, in northwest Portugal. This observation led us to hypothesize that this disorder might be an unrecognized cause of kidney disease in that region and prompted us to carry out targeted genetic testing for the p.Glu545Val variant in the local hemodialysis population and family members of identified cases. | pt_PT |
| dc.description.sponsorship | This work was partially supported by National Funds through the FCT–Fundação para a Ciência e Tecnologia (Portuguese national funding agency for science, research and technology) in the frameworks of the PEst-OE/SAU/UI0215/2014 project–Unit for Multidisciplinary Research in Biomedicine– UMIB/ICBAS/UP; and by a research grant from the Portuguese Society of Nephrology. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Am J Kidney Dis. 2017 Aug;70(2):235-243. doi: 10.1053/j.ajkd.2017.01.048. Epub 2017 Mar 27. | pt_PT |
| dc.identifier.doi | 10.1053/j.ajkd.2017.01.048 | pt_PT |
| dc.identifier.issn | 0272-6386 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/5471 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier/National Kidney Foundation | pt_PT |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S0272-6386(17)30539-5 | pt_PT |
| dc.subject | Aged | pt_PT |
| dc.subject | Amyloidosis | pt_PT |
| dc.subject | Female | pt_PT |
| dc.subject | Fibrinogen | pt_PT |
| dc.subject | Genetic Testing | pt_PT |
| dc.subject | Humans | pt_PT |
| dc.subject | Kidney Diseases | pt_PT |
| dc.subject | Male | pt_PT |
| dc.subject | Middle Aged | pt_PT |
| dc.subject | Retrospective Studies | pt_PT |
| dc.subject | Mutation | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.title | Unrecognized Fibrinogen A α-Chain Amyloidosis: Results From Targeted Genetic Testing | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/5876/PEst-OE%2FSAU%2FUI0215%2F2014/PT | |
| oaire.citation.endPage | 243 | pt_PT |
| oaire.citation.issue | 2 | pt_PT |
| oaire.citation.startPage | 235 | pt_PT |
| oaire.citation.title | American Journal of Kidney Diseases | pt_PT |
| oaire.citation.volume | 70 | pt_PT |
| oaire.fundingStream | 5876 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isProjectOfPublication | 503ef8a3-87a1-4e91-9e1a-49e0702092a6 | |
| relation.isProjectOfPublication.latestForDiscovery | 503ef8a3-87a1-4e91-9e1a-49e0702092a6 |
